SBIR-STTR Award

Antigen production & immunization against infectious hematopoietic necrosis virus
Award last edited on: 3/26/2002

Sponsored Program
SBIR
Awarding Agency
NSF
Total Award Amount
$211,543
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Blake F Grant

Company Information

Rangen Aquaculture Research Center

2928 B South 1175 East
Hagerman, ID 83332
   (208) 837-6191
   rarc@magiclink.com
   www.rangen.com
Location: Single
Congr. District: 02
County: Gooding

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
1985
Phase I Amount
$15,543
Immunization is the only practical control for highly destructive infectious hematopoietic necrosis (IHN) virus infections of trout and salmon. IHN virus grown in cell culture either gives too little antigen or the material is not sufficiently antigenic for use as a killed-vaccine. Butvirus replication and shedding during epizootics produce high levels of natural infectivity and, perhaps, a form having greater immunogenicity. Our objectives are to harvest waterborne infectivity, concentrate and treat it, and test resulting preparations for conferring immunity. The approach is to induce ihn epizootics in trout populations, pass effluents through adsorption media, dissociate concentrated material , kill or modify the virus, contact trout post-larvae with the killed preparations as successfully done with bacterin vaccines, and evaluate potential immunization. If reasonable protection is conferred, the processes are to be optimized and used for vaccine commercialization.

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
1988
Phase II Amount
$196,000
Infectious hematopoietic necrosis virus, salmonid vaccines, immunization, aquaculture immunization is the only practical control for highly destructive infectious hematopoietic necrosis (ihn) virus infections of trout and salmon. Ihn virus grown in cell culture either gives too little antigen or the material is not sufficiently antigenic for use as a killed-vaccine. Butvirus replication and shedding during epizootics produce high levels of natural infectivity and, perhaps, a form having greater immunogenicity. Our objectives are to harvest waterborne infectivity, concentrate and treat it, and test resulting preparations for conferring immunity. The approach is to induce ihn epizootics in trout populations, pass effluents through adsorption media, dissociate concentrated material , kill or modify the virus,contact trout postlarvae with the killed preparations as successfully done with bacterin vaccines, and evaluate potential immunization. If reasonable protection is conferred, the processes are to be optimized and used for vaccine commercialization.